A citation-based method for searching scientific literature

Grace C O'Regan, Sahar H Farag, Gary R Ostroff, Sarah J Tabrizi, Ralph Andre. Sci Rep 2020
Times Cited: 5







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The cryo-electron microscopy structure of huntingtin.
Qiang Guo, Bin Huang, Jingdong Cheng, Manuel Seefelder, Tatjana Engler, Günter Pfeifer, Patrick Oeckl, Markus Otto, Franziska Moser, Melanie Maurer,[...]. Nature 2018
70
60

Huntingtin facilitates dynein/dynactin-mediated vesicle transport.
Juliane P Caviston, Jennifer L Ross, Sheila M Antony, Mariko Tokito, Erika L F Holzbaur. Proc Natl Acad Sci U S A 2007
203
40

Huntingtin protein maintains balanced energetics in mouse cardiomyocytes.
Marta Tomczyk, Talita Glaser, Henning Ulrich, Ewa M Slominska, Ryszard T Smolenski. Nucleosides Nucleotides Nucleic Acids 2022
9
40

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.
Marie Rieux, Melanie Alpaugh, Giacomo Sciacca, Martine Saint-Pierre, Maria Masnata, Hélèna L Denis, Sébastien A Lévesque, Frank Herrmann, Chantal Bazenet, Alexandre P Garneau,[...]. Mol Psychiatry 2021
9
40

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Holly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, Curt Mazur, Melissa M McAlonis, Kimberly A Pytel, Jonathan W Artates, Andreas Weiss, Seng H Cheng, Lamya S Shihabuddin,[...]. Neuron 2012
485
40

Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells.
Ismail Ismailoglu, Qiuying Chen, Melissa Popowski, Lili Yang, Steven S Gross, Ali H Brivanlou. Dev Biol 2014
49
40

Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form.
Huiming Yang, Su Yang, Liang Jing, Luoxiu Huang, Luxiao Chen, Xianxian Zhao, Weili Yang, Yongcheng Pan, Peng Yin, Zhaohui S Qin,[...]. Nat Commun 2020
19
40

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
304
40

Huntingtin functions as a scaffold for selective macroautophagy.
Yan-Ning Rui, Zhen Xu, Bindi Patel, Zhihua Chen, Dongsheng Chen, Antonio Tito, Gabriela David, Yamin Sun, Erin F Stimming, Hugo J Bellen,[...]. Nat Cell Biol 2015
252
40

Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells.
Chih Hung Lo, Nitin K Pandey, Colin Kin-Wye Lim, Zhipeng Ding, Meixin Tao, David D Thomas, Ralf Langen, Jonathan N Sachs. ACS Chem Neurosci 2020
8
40

Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.
M DiFiglia, M Sena-Esteves, K Chase, E Sapp, E Pfister, M Sass, J Yoder, P Reeves, R K Pandey, K G Rajeev,[...]. Proc Natl Acad Sci U S A 2007
301
40

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
797
40

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
Scott Q Harper, Patrick D Staber, Xiaohua He, Steven L Eliason, Inês H Martins, Qinwen Mao, Linda Yang, Robert M Kotin, Henry L Paulson, Beverly L Davidson. Proc Natl Acad Sci U S A 2005
505
40

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
40

Discovery of Small Molecules that Induce the Degradation of Huntingtin.
Shusuke Tomoshige, Sayaka Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa. Angew Chem Int Ed Engl 2017
41
40

Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins.
Hiroko Yamashita, Shusuke Tomoshige, Sayaka Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa. Bioorg Med Chem 2020
10
40

DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.
Georg E Winter, Dennis L Buckley, Joshiawa Paulk, Justin M Roberts, Amanda Souza, Sirano Dhe-Paganon, James E Bradner. Science 2015
786
40

Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.
Zhaoyang Li, Cen Wang, Ziying Wang, Chenggang Zhu, Jie Li, Tian Sha, Lixiang Ma, Chao Gao, Yi Yang, Yimin Sun,[...]. Nature 2019
128
40

The ubiquitin system.
A Hershko, A Ciechanover. Annu Rev Biochem 1998
40

Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative.
Shusuke Tomoshige, Sayaka Nomura, Kenji Ohgane, Yuichi Hashimoto, Minoru Ishikawa. Bioorg Med Chem Lett 2018
15
40


Chemical genetic control of protein levels: selective in vivo targeted degradation.
John S Schneekloth, Fabiana N Fonseca, Michael Koldobskiy, Amit Mandal, Raymond Deshaies, Kathleen Sakamoto, Craig M Crews. J Am Chem Soc 2004
248
40

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4.
Michael Zengerle, Kwok-Ho Chan, Alessio Ciulli. ACS Chem Biol 2015
457
40

Beyond the brain: widespread pathology in Huntington's disease.
Jorien M M van der Burg, Maria Björkqvist, Patrik Brundin. Lancet Neurol 2009
221
40

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
40

The role of chaperone-mediated autophagy in huntingtin degradation.
Lin Qi, Xing-Ding Zhang, Jun-Chao Wu, Fang Lin, Jin Wang, Marian DiFiglia, Zheng-Hong Qin. PLoS One 2012
87
40

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Brinda Ravikumar, Coralie Vacher, Zdenek Berger, Janet E Davies, Shouqing Luo, Lourdes G Oroz, Francesco Scaravilli, Douglas F Easton, Rainer Duden, Cahir J O'Kane,[...]. Nat Genet 2004
40

A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application.
Tianrong Yeo, Megan Sealey, Yifan Zhou, Luisa Saldana, Samantha Loveless, Timothy D W Claridge, Neil Robertson, Gabriele DeLuca, Jacqueline Palace, Daniel C Anthony,[...]. Sci Rep 2020
3
33

The role of metabolomics in neurological disease.
Ghaniah Hassan-Smith, Graham R Wallace, Michael R Douglas, Alexandra J Sinclair. J Neuroimmunol 2012
30
20

12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
E Signoriello, P Iardino, S Casertano, D De Lucia, A Pucciarelli, G Puoti, E Chiosi, G Lus. J Neuroimmunol 2020
4
25

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis.
Santa Mammana, Placido Bramanti, Emanuela Mazzon, Eugenio Cavalli, Maria Sofia Basile, Paolo Fagone, Maria Cristina Petralia, James Andrew McCubrey, Ferdinando Nicoletti, Katia Mangano. Oncotarget 2018
57
20

New opportunities from the cancer metabolome.
Omran Abu Aboud, Robert H Weiss. Clin Chem 2013
59
20

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Laura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, Carmen Espejo. Autoimmun Rev 2018
44
20

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.
Mark S Freedman, Staley Brod, Barry A Singer, Bruce A Cohen, Brooke Hayward, Fernando Dangond, Patricia K Coyle. J Neurol 2020
1
100

EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor.
Ahmed Elkamhawy, Ahmed H E Hassan, Sora Paik, Yong Sup Lee, Hwi-Ho Lee, Ji-Sun Shin, Kyung-Tae Lee, Eun Joo Roh. Bioorg Chem 2019
18
20

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis.
Weipeng Wei, Denglei Ma, Lin Li, Lan Zhang. Front Pharmacol 2021
6
20


Cerebral insulin, insulin signaling pathway, and brain angiogenesis.
Yi Zeng, Le Zhang, Zhiping Hu. Neurol Sci 2016
22
20

Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study.
Marc-Emmanuel Dumas, Elaine C Maibaum, Claire Teague, Hirotsugu Ueshima, Beifan Zhou, John C Lindon, Jeremy K Nicholson, Jeremiah Stamler, Paul Elliott, Queenie Chan,[...]. Anal Chem 2006
236
20

Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
F-M Moussallieh, K Elbayed, J B Chanson, G Rudolf, M Piotto, J De Seze, I J Namer. Mult Scler 2014
28
20

Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis.
J Aasly, M Gårseth, U Sonnewald, J A Zwart, L R White, G Unsgård. Acta Neurol Scand 1997
37
20

Kynurenine metabolism in multiple sclerosis.
Z Hartai, P Klivenyi, T Janaky, B Penke, L Dux, L Vecsei. Acta Neurol Scand 2005
73
20

New perspectives in the natural history of multiple sclerosis.
Helen Tremlett, Yinshan Zhao, Peter Rieckmann, Michael Hutchinson. Neurology 2010
185
20

Curcumin attenuates blood-brain barrier disruption after subarachnoid hemorrhage in mice.
Jichao Yuan, Wei Liu, Haitao Zhu, Xuan Zhang, Yang Feng, Yaxing Chen, Hua Feng, Jiangkai Lin. J Surg Res 2017
32
20

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy.
Lorena Lorefice, Federica Murgia, Giuseppe Fenu, Jessica Frau, Giancarlo Coghe, Maria Rita Murru, Stefania Tranquilli, Andrea Visconti, Maria Giovanna Marrosu, Luigi Atzori,[...]. Neurotherapeutics 2019
8
20

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Bruce Ac Cree, Baldur Magnusson, Nicolas Rouyrre, Robert J Fox, Gavin Giovannoni, Patrick Vermersch, Amit Bar-Or, Ralf Gold, Daniela Piani Meier, Göril Karlsson,[...]. Mult Scler 2021
8
20

Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
S N Reinke, D L Broadhurst, B D Sykes, G B Baker, I Catz, K G Warren, C Power. Mult Scler 2014
66
20

High-resolution 1H NMR spectroscopy of cerebrospinal fluid in spinal diseases.
F Koschorek, W Offermann, J Stelten, W E Braunsdorf, U Steller, H Gremmel, D Leibfritz. Neurosurg Rev 1993
24
20

Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Simone Poddighe, Federica Murgia, Lorena Lorefice, Sonia Liggi, Eleonora Cocco, Maria Giovanna Marrosu, Luigi Atzori. Int J Biochem Cell Biol 2017
37
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.